ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
81.77
-0.97 (-1.17%)
At close: Dec 5, 2025, 4:00 PM EST
82.51
+0.74 (0.90%)
After-hours: Dec 5, 2025, 5:47 PM EST
ANI Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for ANI Pharmaceuticals stock have an average target of 99.29, with a low estimate of 80 and a high estimate of 121. The average target predicts an increase of 21.43% from the current stock price of 81.77.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ANI Pharmaceuticals stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 4 | 4 | 3 | 3 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $114 → $115 | Strong Buy | Maintains | $114 → $115 | +40.64% | Nov 10, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $77 → $90 | Hold | Maintains | $77 → $90 | +10.06% | Oct 9, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $95 → $115 | Buy | Maintains | $95 → $115 | +40.64% | Sep 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $93 → $121 | Strong Buy | Maintains | $93 → $121 | +47.98% | Sep 17, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $86 → $114 | Strong Buy | Maintains | $86 → $114 | +39.42% | Sep 8, 2025 |
Financial Forecast
Revenue This Year
881.05M
from 614.38M
Increased by 43.41%
Revenue Next Year
966.16M
from 881.05M
Increased by 9.66%
EPS This Year
7.60
from -1.04
EPS Next Year
8.34
from 7.60
Increased by 9.78%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 922.4M | 1.1B | ||||
| Avg | 881.1M | 966.2M | ||||
| Low | 819.3M | 894.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 50.1% | 20.0% | ||||
| Avg | 43.4% | 9.7% | ||||
| Low | 33.4% | 1.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 8.00 | 9.08 | ||||
| Avg | 7.60 | 8.34 | ||||
| Low | 7.02 | 7.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 19.6% | ||||
| Avg | - | 9.8% | ||||
| Low | - | -2.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.